G. ANIK İLHAN Et Al. , "The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome," GYNECOLOGICAL ENDOCRINOLOGY , vol.35, no.3, pp.233-236, 2019
ANIK İLHAN, G. Et Al. 2019. The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome. GYNECOLOGICAL ENDOCRINOLOGY , vol.35, no.3 , 233-236.
ANIK İLHAN, G., YILDIZHAN, B., & PEKİN, T., (2019). The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome. GYNECOLOGICAL ENDOCRINOLOGY , vol.35, no.3, 233-236.
ANIK İLHAN, GÖKÇE, BEGÜM YILDIZHAN, And TANJU PEKİN. "The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome," GYNECOLOGICAL ENDOCRINOLOGY , vol.35, no.3, 233-236, 2019
ANIK İLHAN, GÖKÇE A. Et Al. "The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome." GYNECOLOGICAL ENDOCRINOLOGY , vol.35, no.3, pp.233-236, 2019
ANIK İLHAN, G. YILDIZHAN, B. And PEKİN, T. (2019) . "The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome." GYNECOLOGICAL ENDOCRINOLOGY , vol.35, no.3, pp.233-236.
@article{article, author={GÖKÇE ANIK İLHAN Et Al. }, title={The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome}, journal={GYNECOLOGICAL ENDOCRINOLOGY}, year=2019, pages={233-236} }